Pharmadrug
Pharmadrug is a pharmaceutical company based in Canada with significant operations in Germany and the European Union. It specializes in the research, development, and commercialization of controlled substances and natural medicines, including psychedelics and other approved drugs. The company is also involved in the distribution of medical cannabis, both importing and supplying it within Germany and across the EU. Pharmadrug operates under EU-GMP regulations, ensuring compliance with high standards in pharmaceutical manufacturing and distribution.
1 past transactions
Sairiyo Therapeutics
Acquisition in 2021
Sairiyo Therapeutics is a biotechnology company dedicated to repurposing and enhancing formulations of naturally derived compounds to target serious, rare, and life-threatening diseases. The company focuses on developing treatments that have the potential to receive approval from regulatory bodies such as the European Medicines Evaluation Agency and the U.S. Food and Drug Administration. One of its key developments includes cepharanthine, which is being explored for its potential efficacy in treating a range of conditions, including cancer, neurological disorders, inflammatory diseases, and infectious diseases. Through its innovative approach, Sairiyo aims to provide new therapeutic options for patients facing significant health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.